Health

Study finds GLP-1 drugs linked to reduced long-term sick leave

The Hill · July 24, 2026Original source ↗

What happened

A study based on data from Denmark indicates that individuals using GLP-1 drugs experienced a 17% reduction in long-term sick leave. The research analyzed patterns of absence among those taking these medications.

Why it matters

This study may provide insights into the impact of GLP-1 drugs on workforce attendance.

Who feels this

If you are a patient

This study is relevant as it highlights the potential benefits of GLP-1 drugs for managing health conditions. If you are considering these medications, the findings may encourage you to discuss them with your healthcare provider.

If you are a small business owner

The reduction in long-term sick leave among employees using GLP-1 drugs could lead to improved workforce attendance. This may help reduce costs associated with absenteeism and improve overall productivity in your business.

If you are an hourly worker

If you are using GLP-1 drugs, this study suggests that you might experience fewer long-term sick days. This could positively impact your income and job stability, as fewer absences may lead to better job performance.

What does this mean for YOU, specifically?

Ripple builds a profile of your life — your career, your city, your family — and tells you how each story hits it. The analysis above is generic; yours won't be.

Get your Ripple